Fetal Monitoring Market by Product (Ultrasound, Fetal Monitors, Telemetry Devices, Fetal Electrodes), Portability (Portable, Non-portable), Method (Invasive, Non-invasive), Application (Antepartum, Intrapartum), End User, Region - Global Forecast to 2027
The global fetal monitoring market is projected to reach USD 5.2 Billion by 2027 from USD 3.7 Billion in 2022, at a CAGR of 7.3% during the forecast period. Growth in this market is mainly driven by the technological advancements in fetal monitoring products, and the rise in number of gynecological clinics.
'The electronic maternal/fetal monitors accounted for the highest growth rate in the fetal monitoring market, by product, during the forecast period.'
Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. The fastest-growing segment in this market during the forecast period is the fetal monitors. This segment's growth can primarily be attributed to the rising congenital anomalies.
'Non-portable systems segment accounted for the highest CAGR.'
Based on portability, the market is segmented into non-portable systems and portable systems. In 2021, non-portable systems accounted for the largest share because it has more number of applications in hospitals for maternal and fetal well being.
'The hospitals accounted for the highest growth rate in the fetal monitoring market, by end user, during the forecast period.'
The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2021, hospitals accounted for the largest share of this market. The growth of this segments can be attributed to the growing number of births and pregnancies, and initiatives by government for new tools and devices in hospitals.
'Asia Pacific: The fastest-growing region fetal monitoring market.'
The global fetal monitoring market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America was the largest regional market for fetal monitoring. The presence of key players in the region and the better healthcare facilities are the major factors supporting the growth of the fetal monitoring market in North America. However, the Asia Pacific region offers high-growth opportunities for players in the fetal monitoring market. This regional segment is projected to register the highest CAGR during the forecast period. Factors such as ongoing product approvals and launches in the region are factors driving the market growth in the region.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the global fetal monitoring market. It aims at estimating the size and future growth potential of the market across different segments, such as product, portability, method, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall fetal monitoring market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
'The electronic maternal/fetal monitors accounted for the highest growth rate in the fetal monitoring market, by product, during the forecast period.'
Based on products, the fetal monitoring market is segmented into ultrasound devices, electronic maternal/fetal monitors, fetal electrodes, fetal doppler devices, uterine contraction monitors, telemetry devices, accessories & consumables, and other products. The fastest-growing segment in this market during the forecast period is the fetal monitors. This segment's growth can primarily be attributed to the rising congenital anomalies.
'Non-portable systems segment accounted for the highest CAGR.'
Based on portability, the market is segmented into non-portable systems and portable systems. In 2021, non-portable systems accounted for the largest share because it has more number of applications in hospitals for maternal and fetal well being.
'The hospitals accounted for the highest growth rate in the fetal monitoring market, by end user, during the forecast period.'
The market is segmented into hospitals, obstetrics & gynecology clinics, and home care settings based on end users. In 2021, hospitals accounted for the largest share of this market. The growth of this segments can be attributed to the growing number of births and pregnancies, and initiatives by government for new tools and devices in hospitals.
'Asia Pacific: The fastest-growing region fetal monitoring market.'
The global fetal monitoring market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2021, North America was the largest regional market for fetal monitoring. The presence of key players in the region and the better healthcare facilities are the major factors supporting the growth of the fetal monitoring market in North America. However, the Asia Pacific region offers high-growth opportunities for players in the fetal monitoring market. This regional segment is projected to register the highest CAGR during the forecast period. Factors such as ongoing product approvals and launches in the region are factors driving the market growth in the region.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
- By Designation: C-level - 27%, D-level - 18%, and Others - 55%
- By Region: North America - 51%, Europe - 21%, Asia Pacific - 18%, Latin America – 6%, and the Middle East & Africa – 4%
- Cardinal Health, Inc. (US)
- Koninklijke Philips N.V. (Netherlands)
- GE Healthcare (US)
- Siemens Healthineers (Germany)
- FUJIFILM SonoSite, Inc. (US)
- Natus Medical Incorporated (US)
- Huntleigh Healthcare Limited (UK)
- The Cooper Companies Inc. (US)
- CONTEC Medical Systems Co., Ltd. (China)
- EDAN Instruments, Inc. (China)
- Neoventa Medical AB (Sweden)
- Bionet Co., Ltd. (South Korea)
- Progetti Srl (Italy)
- TRISMED Co., Ltd. (Republic of Korea)
- ShenZhen Luckcome Technology Inc. (China)
- MedGyn Products, Inc (US)
- Dixion (Germany)
- Promed Group Co., Ltd. (Hong Kong)
- Advanced Instrumentations (US)
- BRAEL-Medical Equipment (Poland)
- GPC Medical (India)
- BISTOS (Korea)
- Mediana Co. Ltd (Korea)
- Life Plus Medical (India)
- ChoiceMMed (China)
- Trivitron Healthcare (India)
- Dott Medical Co. Ltd. (China)
- Shenzhen Comen Medical Instruments Co., Ltd. (China)
- Shenzhen Vcomin Technology Limited (China)
- Nemo Healthcare (Netherlands)
- MindChild Medical, Inc. (US)
- Melody International Ltd. (Japan)
- Janitri Innovations Pvt. Ltd. (India)
- Laerdal Global Health (Norway)
This report provides a detailed picture of the global fetal monitoring market. It aims at estimating the size and future growth potential of the market across different segments, such as product, portability, method, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall fetal monitoring market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 2 USD EXCHANGE RATES
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 FETAL MONITORING MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
TABLE 3 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 7 APPROACH 3: PARENT MARKET ANALYSIS (ULTRASOUND MARKET)
2.2.1.1 Growth forecast
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
FIGURE 11 FETAL MONITORING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
FIGURE 12 FETAL MONITORING MARKET, BY PORTABILITY, 2022 VS. 2027 (USD BILLION)
FIGURE 13 FETAL MONITORING MARKET, BY METHOD, 2022 VS. 2027 (USD BILLION)
FIGURE 14 FETAL MONITORING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
FIGURE 15 FETAL MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD BILLION)
FIGURE 16 REGIONAL SNAPSHOT OF FETAL MONITORING MARKET
4 PREMIUM INSIGHTS
4.1 FETAL MONITORING MARKET OVERVIEW
FIGURE 17 RISING PRETERM BIRTHS TO DRIVE FETAL MONITORING MARKET
4.2 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD (2021)
FIGURE 18 NON-INVASIVE METHODS ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 REGIONAL GROWTH OPPORTUNITIES IN FETAL MONITORING MARKET
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 FETAL MONITORING MARKET: REGIONAL MIX
FIGURE 20 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
4.5 FETAL MONITORING MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
FIGURE 21 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 FETAL MONITORING MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising number of preterm births and increasing adoption of infertility treatment
5.2.1.2 Advanced and innovative fetal monitoring technologies
5.2.1.3 Government initiatives and increasing collaborations for research by health agencies
5.2.1.4 Reimbursement and insurance policies for fetal monitoring services
TABLE 4 CPT CODES FOR VAGINAL DELIVERIES
5.2.1.5 Active product launches by key manufacturers
5.2.1.6 Increasing number of obstetrics and gynecology centers for fetal monitoring
5.2.2 RESTRAINTS
5.2.2.1 High costs of fetal monitoring equipment
5.2.2.2 Availability of refurbished products
5.2.3 OPPORTUNITIES
5.2.3.1 Development of non-invasive, portable, and advanced fetal monitors
5.2.3.2 Emerging markets and strengthening infrastructure
5.2.4 CHALLENGES
5.2.4.1 Product recalls
TABLE 5 PRODUCT RECALLS IN FETAL MONITORING MARKET
5.2.4.2 Lack of skilled healthcare professionals
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 23 DIRECT DISTRIBUTION – PREFERRED STRATEGY OF PROMINENT COMPANIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 24 FETAL MONITORING MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 25 FETAL MONITORING MARKET: ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
FIGURE 26 KEY PLAYERS IN FETAL MONITORING MARKET ECOSYSTEM
5.6 REGULATORY LANDSCAPE
TABLE 6 REGULATORY AUTHORITIES
5.6.1 EU REGULATIONS
5.6.2 US REGULATIONS
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 INTENSITY OF COMPETITIVE RIVALRY
5.7.5 THREAT OF SUBSTITUTES
5.8 PATENT ANALYSIS OF FETAL MONITORING PRODUCTS
FIGURE 27 PATENT ANALYSIS: UTERINE CONTRACTION MONITORS (2013–NOVEMBER 2022)
FIGURE 28 PATENT ANALYSIS: FETAL DOPPLERS (2013–NOVEMBER 2022)
FIGURE 29 PATENT ANALYSIS: FETAL ELECTRODES (2013–NOVEMBER 2022)
5.9 TRADE ANALYSIS FOR ULTRASOUND
5.9.1 IMPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION)
5.9.2 EXPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION)
5.10 TECHNOLOGY ANALYSIS
TABLE 7 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS
6 FETAL MONITORING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 8 FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 ULTRASOUND DEVICES
TABLE 9 ULTRASOUND DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 10 ULTRASOUND DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1 2D ULTRASOUND
6.2.1.1 Increasing commercialization of innovative 2D technologies
TABLE 11 2D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 3D & 4D ULTRASOUND
6.2.2.1 Technological advantages of 3D & 4D ultrasound over 2D ultrasound
TABLE 12 3D & 4D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.3 DOPPLER IMAGING
6.2.3.1 Doppler imaging vital to analyze hemodynamics in fetal surveillance
TABLE 13 DOPPLER IMAGING: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 ELECTRONIC MATERNAL/FETAL MONITORS
6.3.1 RISING NUMBER OF HIGH-RISK PREGNANCIES
TABLE 14 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 FETAL ELECTRODES
6.4.1 NEED FOR INTRAPARTUM FETAL SURVEILLANCE
TABLE 15 FETAL ELECTRODES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5 FETAL DOPPLER DEVICES
6.5.1 INCREASING USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS
TABLE 16 FETAL DOPPLER DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6 UTERINE CONTRACTION MONITORS
TABLE 17 UTERINE CONTRACTION MONITORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 18 UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.1 INTERNAL UTERINE CONTRACTION MONITORS
6.6.1.1 Accurate measurements obtained by internal UCMs
TABLE 19 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS
6.6.2.1 Developments underway to overcome drawbacks of external UCMs
TABLE 20 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7 TELEMETRY DEVICES
6.7.1 REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES
TABLE 21 TELEMETRY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8 ACCESSORIES & CONSUMABLES
6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO INCREASING UTILIZATION OF ACCESSORIES & CONSUMABLES
TABLE 22 ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9 OTHER PRODUCTS
TABLE 23 OTHER PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
7 FETAL MONITORING MARKET, BY PORTABILITY
7.1 INTRODUCTION
TABLE 24 FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
7.2 NON-PORTABLE SYSTEMS
7.2.1 TECHNOLOGICAL ADVANCEMENTS IN NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH
TABLE 25 NON-PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3 PORTABLE SYSTEMS
7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS TO DRIVE MARKET GROWTH
TABLE 26 PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
8 FETAL MONITORING MARKET, BY METHOD
8.1 INTRODUCTION
TABLE 27 FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
8.2 NON-INVASIVE METHOD
8.2.1 NON-INVASIVE METHODS WIDELY ADOPTED IN HIGH-RISK PREGNANCIES
TABLE 28 NON-INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3 INVASIVE METHOD
8.3.1 CONSISTENT TRANSMISSION OF FETAL HEART RATE POSSIBLE VIA INVASIVE METHODS
TABLE 29 INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
9 FETAL MONITORING MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 30 FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2 ANTEPARTUM
9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH
TABLE 31 ANTEPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3 INTRAPARTUM
9.3.1 FAVORABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH
TABLE 32 INTRAPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
10 FETAL MONITORING MARKET, BY END USER
10.1 INTRODUCTION
TABLE 33 FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2 HOSPITALS
10.2.1 AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH
TABLE 34 HOSPITALS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
10.3 OBSTETRICS & GYNECOLOGY CLINICS
10.3.1 RISING EMPHASIS ON PERINATAL CARE TO BOLSTER GROWTH OF SEGMENT
TABLE 35 OBSTETRICS & GYNECOLOGY CLINICS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
10.4 HOME CARE SETTINGS
10.4.1 REMOTE CARE BY PORTABLE FETAL MONITORING SYSTEMS TO DRIVE GROWTH
TABLE 36 HOME CARE SETTINGS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
11 FETAL MONITORING MARKET, BY REGION
11.1 INTRODUCTION
TABLE 37 FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT
TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.1 RECESSION IMPACT
11.2.2 US
11.2.2.1 US held largest share of North American market in 2021
FIGURE 31 US: PRETERM BIRTH RATE, BY RACE/ETHNICITY, 2018–2020 (AVERAGE)
TABLE 46 ULTRASOUND CPT CODES
TABLE 47 US: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 48 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 51 US: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 52 US: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 US: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Growing government initiatives for fetal and maternal care to drive market growth in Canada
FIGURE 32 CANADA: NUMBER OF BIRTHS, 2011 TO 2021
TABLE 54 CANADA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 55 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 58 CANADA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 59 CANADA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 60 CANADA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3 EUROPE
TABLE 61 EUROPE: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 66 EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 EUROPE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.1 RECESSION IMPACT
11.3.2 GERMANY
11.3.2.1 Increasing healthcare expenditure to support market growth in Germany
TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 73 GERMANY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 74 GERMANY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 75 GERMANY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.3 UK
11.3.3.1 Rising emphasis on better maternity services to drive market growth in UK
TABLE 76 UK: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 77 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 UK: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 80 UK: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 81 UK: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 82 UK: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Increasing focus on healthcare policies to accelerate market growth in France
TABLE 83 FRANCE: HEALTHCARE SPENDING, 2011–2019
TABLE 84 FRANCE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 85 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 88 FRANCE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 89 FRANCE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 90 FRANCE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Increasing healthcare expenditure to propel growth of market in Italy
TABLE 91 ITALY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 92 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 ITALY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 95 ITALY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 96 ITALY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 97 ITALY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Declining birth rate to restrain growth of market in Spain
TABLE 98 SPAIN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 102 SPAIN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 103 SPAIN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 SPAIN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 105 REST OF EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 REST OF EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 REST OF EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 REST OF EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 109 REST OF EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 110 REST OF EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 111 REST OF EUROPE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT
11.4.1 RECESSION IMPACT
TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 117 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 118 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Increasing focus on launch of innovative products to propel market growth in Japan
TABLE 120 JAPAN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 124 JAPAN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 125 JAPAN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 126 JAPAN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Developing healthcare infrastructure in China to support market growth
TABLE 127 CHINA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 128 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 CHINA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 131 CHINA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 132 CHINA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 133 CHINA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Growing number of preterm births to drive market growth in India
TABLE 134 INDIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 135 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 INDIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 138 INDIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 139 INDIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 140 INDIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Increasing implementation of ultrasound technology to drive market in South Korea
TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 145 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 146 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 147 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.6 AUSTRALIA
11.4.6.1 Rising emphasis on maternal care to bolster market growth in Australia
TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 149 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 152 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 153 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 154 AUSTRALIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 155 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 156 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 159 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 160 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 161 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5 REST OF THE WORLD
11.5.1 RECESSION IMPACT
TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 167 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 168 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 169 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.2 LATIN AMERICA
11.5.2.1 Favorable government policies to support growth of market
TABLE 170 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.3 MIDDLE EAST & AFRICA
11.5.3.1 High number of pre-term births recorded to boost market
TABLE 177 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 184 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 34 REVENUE SHARE ANALYSIS OF TOP PLAYERS
12.4 MARKET SHARE ANALYSIS
FIGURE 35 FETAL MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
12.5 COMPANY EVALUATION QUADRANT (2021)
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 36 FETAL MONITORING MARKET: COMPANY EVALUATION QUADRANT, 2021
12.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
FIGURE 37 FETAL MONITORING MARKET: START-UP/SME EVALUATION QUADRANT, 2021
12.7 COMPETITIVE BENCHMARKING
TABLE 185 FETAL MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 186 PRODUCT FOOTPRINT OF KEY PLAYERS
TABLE 187 REGIONAL FOOTPRINT OF KEY PLAYERS
12.8 COMPETITIVE SCENARIO
12.8.1 PRODUCT LAUNCHES
TABLE 188 PRODUCT LAUNCHES, 2019–NOVEMBER 2022
12.8.2 DEALS
TABLE 189 DEALS, 2019–NOVEMBER 2022
12.8.3 OTHER DEVELOPMENTS
TABLE 190 OTHER DEVELOPMENTS, 2019–NOVEMBER 2022
13 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
13.1 KEY PLAYERS
13.1.1 GE HEALTHCARE
TABLE 191 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 38 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 192 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 193 GE HEALTHCARE: DEALS
13.1.2 SIEMENS HEALTHINEERS
TABLE 194 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 39 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 195 SIEMENS HEALTHINEERS: PRODUCTS OFFERED
TABLE 196 SIEMENS HEALTHINEERS: DEALS
13.1.3 CARDINAL HEALTH, INC.
TABLE 197 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 40 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
TABLE 198 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
13.1.4 KONINKLIJKE PHILIPS N.V.
TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 200 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 201 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
13.1.5 FUJIFILM SONOSITE, INC.
TABLE 202 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW
FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 203 FUJIFILM SONOSITE, INC.: PRODUCTS OFFERED
TABLE 204 FUJIFILM SONOSITE, INC.: PRODUCT LAUNCHES
TABLE 205 FUJIFILM SONOSITE, INC.: DEALS
13.1.6 HUNTLEIGH HEALTHCARE LIMITED
TABLE 206 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW
FIGURE 43 ARJO: COMPANY SNAPSHOT
TABLE 207 HUNTLEIGH HEALTHCARE LIMITED: PRODUCTS OFFERED
13.1.7 NATUS MEDICAL INCORPORATED
TABLE 208 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW
FIGURE 44 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 209 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED
TABLE 210 NATUS MEDICAL INCORPORATED: DEALS
13.1.8 THE COOPER COMPANIES, INC.
TABLE 211 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW
FIGURE 45 THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT
TABLE 212 THE COOPER COMPANIES, INC.: PRODUCTS OFFERED
TABLE 213 THE COOPER COMPANIES, INC.: DEALS
13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD.
TABLE 214 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
TABLE 215 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
TABLE 216 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES
TABLE 217 CONTEC MEDICAL SYSTEMS CO., LTD.: DEALS
13.1.10 EDAN INSTRUMENTS, INC.
TABLE 218 EDAN INSTRUMENTS, INC.: BUSINESS OVERVIEW
TABLE 219 EDAN INSTRUMENTS, INC.: PRODUCTS OFFERED
TABLE 220 EDAN INSTRUMENTS, INC.: DEALS
TABLE 221 EDAN INSTRUMENTS, INC.: OTHER DEVELOPMENTS
13.2 OTHER PLAYERS
13.2.1 NEOVENTA MEDICAL AB
13.2.2 BIONET CO., LTD.
13.2.3 PROGETTI SRL
13.2.4 TRISMED CO., LTD.
13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC., LTD.
13.2.6 MEDGYN PRODUCTS, INC.
13.2.7 DIXION
13.2.8 PROMED TECHNOLOGY CO., LTD.
13.2.9 ADVANCED INSTRUMENTATIONS
13.2.10 BRAEL-MEDICAL EQUIPMENT
13.2.11 GPC MEDICAL LTD.
13.2.12 SHENZHEN VCOMIN TECHNOLOGY LIMITED
13.2.13 BISTOS CO., LTD.
13.2.14 MEDIANA CO., LTD.
13.2.15 LIFE PLUS HEALTHCARE (P) LTD.
13.2.16 CHOICEMMED
13.2.17 TRIVITRON HEALTHCARE
13.2.18 DOTT MEDICAL CO. LTD.
13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
13.2.20 NEMO HEALTHCARE
13.2.21 MINDCHILD MEDICAL, INC.
13.2.22 MELODY INTERNATIONAL LTD.
13.2.23 JANITRI INNOVATIONS PVT. LTD.
13.2.24 LAERDAL GLOBAL HEALTH
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INDUSTRY INSIGHTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 CUSTOMIZATION OPTIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 2 USD EXCHANGE RATES
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 LIMITATIONS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 FETAL MONITORING MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
TABLE 3 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 KEY INDUSTRY INSIGHTS
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
FIGURE 6 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 7 APPROACH 3: PARENT MARKET ANALYSIS (ULTRASOUND MARKET)
2.2.1.1 Growth forecast
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY
FIGURE 11 FETAL MONITORING MARKET, BY PRODUCT, 2022 VS. 2027 (USD BILLION)
FIGURE 12 FETAL MONITORING MARKET, BY PORTABILITY, 2022 VS. 2027 (USD BILLION)
FIGURE 13 FETAL MONITORING MARKET, BY METHOD, 2022 VS. 2027 (USD BILLION)
FIGURE 14 FETAL MONITORING MARKET, BY APPLICATION, 2022 VS. 2027 (USD BILLION)
FIGURE 15 FETAL MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD BILLION)
FIGURE 16 REGIONAL SNAPSHOT OF FETAL MONITORING MARKET
4 PREMIUM INSIGHTS
4.1 FETAL MONITORING MARKET OVERVIEW
FIGURE 17 RISING PRETERM BIRTHS TO DRIVE FETAL MONITORING MARKET
4.2 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD (2021)
FIGURE 18 NON-INVASIVE METHODS ACCOUNTED FOR LARGEST SHARE IN 2021
4.3 REGIONAL GROWTH OPPORTUNITIES IN FETAL MONITORING MARKET
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 FETAL MONITORING MARKET: REGIONAL MIX
FIGURE 20 ASIA PACIFIC MARKET TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
4.5 FETAL MONITORING MARKET: DEVELOPED VS. DEVELOPING ECONOMIES
FIGURE 21 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 22 FETAL MONITORING MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising number of preterm births and increasing adoption of infertility treatment
5.2.1.2 Advanced and innovative fetal monitoring technologies
5.2.1.3 Government initiatives and increasing collaborations for research by health agencies
5.2.1.4 Reimbursement and insurance policies for fetal monitoring services
TABLE 4 CPT CODES FOR VAGINAL DELIVERIES
5.2.1.5 Active product launches by key manufacturers
5.2.1.6 Increasing number of obstetrics and gynecology centers for fetal monitoring
5.2.2 RESTRAINTS
5.2.2.1 High costs of fetal monitoring equipment
5.2.2.2 Availability of refurbished products
5.2.3 OPPORTUNITIES
5.2.3.1 Development of non-invasive, portable, and advanced fetal monitors
5.2.3.2 Emerging markets and strengthening infrastructure
5.2.4 CHALLENGES
5.2.4.1 Product recalls
TABLE 5 PRODUCT RECALLS IN FETAL MONITORING MARKET
5.2.4.2 Lack of skilled healthcare professionals
5.3 SUPPLY CHAIN ANALYSIS
FIGURE 23 DIRECT DISTRIBUTION – PREFERRED STRATEGY OF PROMINENT COMPANIES
5.4 VALUE CHAIN ANALYSIS
FIGURE 24 FETAL MONITORING MARKET: VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 25 FETAL MONITORING MARKET: ECOSYSTEM ANALYSIS
5.5.1 ROLE IN ECOSYSTEM
FIGURE 26 KEY PLAYERS IN FETAL MONITORING MARKET ECOSYSTEM
5.6 REGULATORY LANDSCAPE
TABLE 6 REGULATORY AUTHORITIES
5.6.1 EU REGULATIONS
5.6.2 US REGULATIONS
5.7 PORTER'S FIVE FORCES ANALYSIS
5.7.1 THREAT FROM NEW ENTRANTS
5.7.2 BARGAINING POWER OF SUPPLIERS
5.7.3 BARGAINING POWER OF BUYERS
5.7.4 INTENSITY OF COMPETITIVE RIVALRY
5.7.5 THREAT OF SUBSTITUTES
5.8 PATENT ANALYSIS OF FETAL MONITORING PRODUCTS
FIGURE 27 PATENT ANALYSIS: UTERINE CONTRACTION MONITORS (2013–NOVEMBER 2022)
FIGURE 28 PATENT ANALYSIS: FETAL DOPPLERS (2013–NOVEMBER 2022)
FIGURE 29 PATENT ANALYSIS: FETAL ELECTRODES (2013–NOVEMBER 2022)
5.9 TRADE ANALYSIS FOR ULTRASOUND
5.9.1 IMPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION)
5.9.2 EXPORT DATA FOR ULTRASOUND, BY COUNTRY, 2017–2021 (USD MILLION)
5.10 TECHNOLOGY ANALYSIS
TABLE 7 AVERAGE SELLING PRICE OF FETAL MONITORING PRODUCTS
6 FETAL MONITORING MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 8 FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 ULTRASOUND DEVICES
TABLE 9 ULTRASOUND DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 10 ULTRASOUND DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.1 2D ULTRASOUND
6.2.1.1 Increasing commercialization of innovative 2D technologies
TABLE 11 2D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.2 3D & 4D ULTRASOUND
6.2.2.1 Technological advantages of 3D & 4D ultrasound over 2D ultrasound
TABLE 12 3D & 4D ULTRASOUND: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
6.2.3 DOPPLER IMAGING
6.2.3.1 Doppler imaging vital to analyze hemodynamics in fetal surveillance
TABLE 13 DOPPLER IMAGING: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 ELECTRONIC MATERNAL/FETAL MONITORS
6.3.1 RISING NUMBER OF HIGH-RISK PREGNANCIES
TABLE 14 ELECTRONIC MATERNAL/FETAL MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.4 FETAL ELECTRODES
6.4.1 NEED FOR INTRAPARTUM FETAL SURVEILLANCE
TABLE 15 FETAL ELECTRODES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.5 FETAL DOPPLER DEVICES
6.5.1 INCREASING USE OF FETAL DOPPLERS IN-HOME CARE SETTINGS
TABLE 16 FETAL DOPPLER DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6 UTERINE CONTRACTION MONITORS
TABLE 17 UTERINE CONTRACTION MONITORS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 18 UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.1 INTERNAL UTERINE CONTRACTION MONITORS
6.6.1.1 Accurate measurements obtained by internal UCMs
TABLE 19 INTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.6.2 EXTERNAL UTERINE CONTRACTION MONITORS
6.6.2.1 Developments underway to overcome drawbacks of external UCMs
TABLE 20 EXTERNAL UTERINE CONTRACTION MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)
6.7 TELEMETRY DEVICES
6.7.1 REMOTE MONITORING INCORPORATED INTO TELEMETRY DEVICES
TABLE 21 TELEMETRY DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.8 ACCESSORIES & CONSUMABLES
6.8.1 ADVANCEMENTS IN FETAL MONITORING TO LEAD TO INCREASING UTILIZATION OF ACCESSORIES & CONSUMABLES
TABLE 22 ACCESSORIES & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
6.9 OTHER PRODUCTS
TABLE 23 OTHER PRODUCTS MARKET, BY REGION, 2020–2027 (USD MILLION)
7 FETAL MONITORING MARKET, BY PORTABILITY
7.1 INTRODUCTION
TABLE 24 FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
7.2 NON-PORTABLE SYSTEMS
7.2.1 TECHNOLOGICAL ADVANCEMENTS IN NON-PORTABLE SYSTEMS TO SUPPORT MARKET GROWTH
TABLE 25 NON-PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
7.3 PORTABLE SYSTEMS
7.3.1 REMOTE ACCURACY OFFERED BY PORTABLE SYSTEMS TO DRIVE MARKET GROWTH
TABLE 26 PORTABLE SYSTEMS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
8 FETAL MONITORING MARKET, BY METHOD
8.1 INTRODUCTION
TABLE 27 FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
8.2 NON-INVASIVE METHOD
8.2.1 NON-INVASIVE METHODS WIDELY ADOPTED IN HIGH-RISK PREGNANCIES
TABLE 28 NON-INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
8.3 INVASIVE METHOD
8.3.1 CONSISTENT TRANSMISSION OF FETAL HEART RATE POSSIBLE VIA INVASIVE METHODS
TABLE 29 INVASIVE FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
9 FETAL MONITORING MARKET, BY APPLICATION
9.1 INTRODUCTION
TABLE 30 FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
9.2 ANTEPARTUM
9.2.1 INCREASING INCIDENCES OF PREGNANCY-RELATED COMPLICATIONS TO SUPPORT GROWTH
TABLE 31 ANTEPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
9.3 INTRAPARTUM
9.3.1 FAVORABLE GUIDELINES BY HEALTHCARE AUTHORITIES TO PROPEL GROWTH
TABLE 32 INTRAPARTUM FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
10 FETAL MONITORING MARKET, BY END USER
10.1 INTRODUCTION
TABLE 33 FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2 HOSPITALS
10.2.1 AVAILABILITY OF WELL-ESTABLISHED HEALTHCARE INFRASTRUCTURE TO DRIVE SEGMENT GROWTH
TABLE 34 HOSPITALS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
10.3 OBSTETRICS & GYNECOLOGY CLINICS
10.3.1 RISING EMPHASIS ON PERINATAL CARE TO BOLSTER GROWTH OF SEGMENT
TABLE 35 OBSTETRICS & GYNECOLOGY CLINICS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
10.4 HOME CARE SETTINGS
10.4.1 REMOTE CARE BY PORTABLE FETAL MONITORING SYSTEMS TO DRIVE GROWTH
TABLE 36 HOME CARE SETTINGS: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
11 FETAL MONITORING MARKET, BY REGION
11.1 INTRODUCTION
TABLE 37 FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 30 NORTH AMERICA: FETAL MONITORING MARKET SNAPSHOT
TABLE 38 NORTH AMERICA: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 NORTH AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 40 NORTH AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 43 NORTH AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.1 RECESSION IMPACT
11.2.2 US
11.2.2.1 US held largest share of North American market in 2021
FIGURE 31 US: PRETERM BIRTH RATE, BY RACE/ETHNICITY, 2018–2020 (AVERAGE)
TABLE 46 ULTRASOUND CPT CODES
TABLE 47 US: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 48 US: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 US: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 51 US: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 52 US: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 53 US: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Growing government initiatives for fetal and maternal care to drive market growth in Canada
FIGURE 32 CANADA: NUMBER OF BIRTHS, 2011 TO 2021
TABLE 54 CANADA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 55 CANADA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 CANADA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 58 CANADA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 59 CANADA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 60 CANADA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3 EUROPE
TABLE 61 EUROPE: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 66 EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 68 EUROPE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.1 RECESSION IMPACT
11.3.2 GERMANY
11.3.2.1 Increasing healthcare expenditure to support market growth in Germany
TABLE 69 GERMANY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 70 GERMANY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 GERMANY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 GERMANY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 73 GERMANY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 74 GERMANY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 75 GERMANY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.3 UK
11.3.3.1 Rising emphasis on better maternity services to drive market growth in UK
TABLE 76 UK: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 77 UK: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 UK: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 79 UK: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 80 UK: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 81 UK: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 82 UK: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.4 FRANCE
11.3.4.1 Increasing focus on healthcare policies to accelerate market growth in France
TABLE 83 FRANCE: HEALTHCARE SPENDING, 2011–2019
TABLE 84 FRANCE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 85 FRANCE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 FRANCE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 FRANCE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 88 FRANCE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 89 FRANCE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 90 FRANCE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.5 ITALY
11.3.5.1 Increasing healthcare expenditure to propel growth of market in Italy
TABLE 91 ITALY: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 92 ITALY: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 ITALY: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 ITALY: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 95 ITALY: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 96 ITALY: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 97 ITALY: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.6 SPAIN
11.3.6.1 Declining birth rate to restrain growth of market in Spain
TABLE 98 SPAIN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 99 SPAIN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 SPAIN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 SPAIN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 102 SPAIN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 103 SPAIN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 SPAIN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 105 REST OF EUROPE: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 106 REST OF EUROPE: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 REST OF EUROPE: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 108 REST OF EUROPE: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 109 REST OF EUROPE: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 110 REST OF EUROPE: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 111 REST OF EUROPE: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 33 ASIA PACIFIC: FETAL MONITORING MARKET SNAPSHOT
11.4.1 RECESSION IMPACT
TABLE 112 ASIA PACIFIC: FETAL MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 113 ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 114 ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 117 ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 118 ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Increasing focus on launch of innovative products to propel market growth in Japan
TABLE 120 JAPAN: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 121 JAPAN: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 122 JAPAN: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 123 JAPAN: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 124 JAPAN: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 125 JAPAN: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 126 JAPAN: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Developing healthcare infrastructure in China to support market growth
TABLE 127 CHINA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 128 CHINA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 129 CHINA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 130 CHINA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 131 CHINA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 132 CHINA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 133 CHINA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.4 INDIA
11.4.4.1 Growing number of preterm births to drive market growth in India
TABLE 134 INDIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 135 INDIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 INDIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 137 INDIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 138 INDIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 139 INDIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 140 INDIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Increasing implementation of ultrasound technology to drive market in South Korea
TABLE 141 SOUTH KOREA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 142 SOUTH KOREA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 143 SOUTH KOREA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 SOUTH KOREA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 145 SOUTH KOREA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 146 SOUTH KOREA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 147 SOUTH KOREA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.6 AUSTRALIA
11.4.6.1 Rising emphasis on maternal care to bolster market growth in Australia
TABLE 148 AUSTRALIA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 149 AUSTRALIA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 150 AUSTRALIA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 151 AUSTRALIA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 152 AUSTRALIA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 153 AUSTRALIA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 154 AUSTRALIA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 155 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 156 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 157 REST OF ASIA PACIFIC: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 158 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 159 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 160 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 161 REST OF ASIA PACIFIC: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5 REST OF THE WORLD
11.5.1 RECESSION IMPACT
TABLE 162 REST OF THE WORLD: FETAL MONITORING MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 163 REST OF THE WORLD: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 164 REST OF THE WORLD: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 165 REST OF THE WORLD: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 REST OF THE WORLD: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 167 REST OF THE WORLD: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 168 REST OF THE WORLD: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 169 REST OF THE WORLD: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.2 LATIN AMERICA
11.5.2.1 Favorable government policies to support growth of market
TABLE 170 LATIN AMERICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 175 LATIN AMERICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 176 LATIN AMERICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
11.5.3 MIDDLE EAST & AFRICA
11.5.3.1 High number of pre-term births recorded to boost market
TABLE 177 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR ULTRASOUND DEVICES, BY TYPE, 2020–2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET FOR UTERINE CONTRACTION MONITORS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY PORTABILITY, 2020–2027 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY METHOD, 2020–2027 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 183 MIDDLE EAST & AFRICA: FETAL MONITORING MARKET, BY END USER, 2020–2027 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 184 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 34 REVENUE SHARE ANALYSIS OF TOP PLAYERS
12.4 MARKET SHARE ANALYSIS
FIGURE 35 FETAL MONITORING MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
12.5 COMPANY EVALUATION QUADRANT (2021)
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 36 FETAL MONITORING MARKET: COMPANY EVALUATION QUADRANT, 2021
12.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021)
12.6.1 PROGRESSIVE COMPANIES
12.6.2 STARTING BLOCKS
12.6.3 RESPONSIVE COMPANIES
12.6.4 DYNAMIC COMPANIES
FIGURE 37 FETAL MONITORING MARKET: START-UP/SME EVALUATION QUADRANT, 2021
12.7 COMPETITIVE BENCHMARKING
TABLE 185 FETAL MONITORING MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 186 PRODUCT FOOTPRINT OF KEY PLAYERS
TABLE 187 REGIONAL FOOTPRINT OF KEY PLAYERS
12.8 COMPETITIVE SCENARIO
12.8.1 PRODUCT LAUNCHES
TABLE 188 PRODUCT LAUNCHES, 2019–NOVEMBER 2022
12.8.2 DEALS
TABLE 189 DEALS, 2019–NOVEMBER 2022
12.8.3 OTHER DEVELOPMENTS
TABLE 190 OTHER DEVELOPMENTS, 2019–NOVEMBER 2022
13 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) *
13.1 KEY PLAYERS
13.1.1 GE HEALTHCARE
TABLE 191 GE HEALTHCARE: BUSINESS OVERVIEW
FIGURE 38 GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT
TABLE 192 GE HEALTHCARE: PRODUCTS OFFERED
TABLE 193 GE HEALTHCARE: DEALS
13.1.2 SIEMENS HEALTHINEERS
TABLE 194 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
FIGURE 39 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
TABLE 195 SIEMENS HEALTHINEERS: PRODUCTS OFFERED
TABLE 196 SIEMENS HEALTHINEERS: DEALS
13.1.3 CARDINAL HEALTH, INC.
TABLE 197 CARDINAL HEALTH, INC.: BUSINESS OVERVIEW
FIGURE 40 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT
TABLE 198 CARDINAL HEALTH, INC.: PRODUCTS OFFERED
13.1.4 KONINKLIJKE PHILIPS N.V.
TABLE 199 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 200 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED
TABLE 201 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES
13.1.5 FUJIFILM SONOSITE, INC.
TABLE 202 FUJIFILM SONOSITE, INC.: BUSINESS OVERVIEW
FIGURE 42 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 203 FUJIFILM SONOSITE, INC.: PRODUCTS OFFERED
TABLE 204 FUJIFILM SONOSITE, INC.: PRODUCT LAUNCHES
TABLE 205 FUJIFILM SONOSITE, INC.: DEALS
13.1.6 HUNTLEIGH HEALTHCARE LIMITED
TABLE 206 HUNTLEIGH HEALTHCARE LIMITED: BUSINESS OVERVIEW
FIGURE 43 ARJO: COMPANY SNAPSHOT
TABLE 207 HUNTLEIGH HEALTHCARE LIMITED: PRODUCTS OFFERED
13.1.7 NATUS MEDICAL INCORPORATED
TABLE 208 NATUS MEDICAL INCORPORATED: BUSINESS OVERVIEW
FIGURE 44 NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 209 NATUS MEDICAL INCORPORATED: PRODUCTS OFFERED
TABLE 210 NATUS MEDICAL INCORPORATED: DEALS
13.1.8 THE COOPER COMPANIES, INC.
TABLE 211 THE COOPER COMPANIES, INC.: BUSINESS OVERVIEW
FIGURE 45 THE COOPER COMPANIES, INC.: COMPANY SNAPSHOT
TABLE 212 THE COOPER COMPANIES, INC.: PRODUCTS OFFERED
TABLE 213 THE COOPER COMPANIES, INC.: DEALS
13.1.9 CONTEC MEDICAL SYSTEMS CO., LTD.
TABLE 214 CONTEC MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
TABLE 215 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCTS OFFERED
TABLE 216 CONTEC MEDICAL SYSTEMS CO., LTD.: PRODUCT LAUNCHES
TABLE 217 CONTEC MEDICAL SYSTEMS CO., LTD.: DEALS
13.1.10 EDAN INSTRUMENTS, INC.
TABLE 218 EDAN INSTRUMENTS, INC.: BUSINESS OVERVIEW
TABLE 219 EDAN INSTRUMENTS, INC.: PRODUCTS OFFERED
TABLE 220 EDAN INSTRUMENTS, INC.: DEALS
TABLE 221 EDAN INSTRUMENTS, INC.: OTHER DEVELOPMENTS
13.2 OTHER PLAYERS
13.2.1 NEOVENTA MEDICAL AB
13.2.2 BIONET CO., LTD.
13.2.3 PROGETTI SRL
13.2.4 TRISMED CO., LTD.
13.2.5 SHENZHEN LUCKCOME TECHNOLOGY INC., LTD.
13.2.6 MEDGYN PRODUCTS, INC.
13.2.7 DIXION
13.2.8 PROMED TECHNOLOGY CO., LTD.
13.2.9 ADVANCED INSTRUMENTATIONS
13.2.10 BRAEL-MEDICAL EQUIPMENT
13.2.11 GPC MEDICAL LTD.
13.2.12 SHENZHEN VCOMIN TECHNOLOGY LIMITED
13.2.13 BISTOS CO., LTD.
13.2.14 MEDIANA CO., LTD.
13.2.15 LIFE PLUS HEALTHCARE (P) LTD.
13.2.16 CHOICEMMED
13.2.17 TRIVITRON HEALTHCARE
13.2.18 DOTT MEDICAL CO. LTD.
13.2.19 SHENZHEN COMEN MEDICAL INSTRUMENTS CO., LTD.
13.2.20 NEMO HEALTHCARE
13.2.21 MINDCHILD MEDICAL, INC.
13.2.22 MELODY INTERNATIONAL LTD.
13.2.23 JANITRI INNOVATIONS PVT. LTD.
13.2.24 LAERDAL GLOBAL HEALTH
*Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.
14 APPENDIX
14.1 INDUSTRY INSIGHTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 CUSTOMIZATION OPTIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS
